Lv6
2200 积分 2024-03-29 加入
EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
5天前
已完结
Chirality Dependent Potency Enhancement and Structural Impact of Glycol Nucleic Acid Modification on siRNA
7天前
已完结
Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
10天前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
21天前
已完结
Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice
1个月前
已完结
Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice
1个月前
已关闭
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
1个月前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
1个月前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
2个月前
已完结
Abstract 6805: DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis
2个月前
已完结
皖公网安备34019202002308
